Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
Adma Biologics (ADMA) Recently Broke Out Above the 200-Day Moving Average
10:30am, Tuesday, 25'th Nov 2025
After reaching an important support level, Adma Biologics (ADMA) could be a good stock pick from a technical perspective. ADMA surpassed resistance at the 200-day moving average, suggesting a long-ter
ADMA Biologics: Why The Dip To $16 Resets The Buy Case
04:35pm, Thursday, 20'th Nov 2025
ADMA Biologics remains a Buy as Q3 results and 2026 guidance support a bullish long-term outlook. ADMA's Asceniv drives robust revenue and margin expansion, with 2026 revenue guided at $630M and EBITD
Envestnet Asset Management Inc. Grows Stock Holdings in ADMA Biologics Inc $ADMA
05:03am, Monday, 17'th Nov 2025
Envestnet Asset Management Inc. boosted its stake in shares of ADMA Biologics Inc (NASDAQ: ADMA) by 108.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchan
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?
10:30am, Friday, 14'th Nov 2025
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy?
10:35am, Wednesday, 12'th Nov 2025
From a technical perspective, Adma Biologics (ADMA) is looking like an interesting pick, as it just reached a key level of support. ADMA recently overtook the 20-day moving average, and this suggests
Adma Biologics (ADMA) Crossed Above the 50-Day Moving Average: What That Means for Investors
10:31am, Wednesday, 12'th Nov 2025
Adma Biologics (ADMA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ADMA broke through the 50-day moving average, which suggests a
Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 108.5%: Here's is How to Trade
10:55am, Tuesday, 11'th Nov 2025
The consensus price target hints at a 108.5% upside potential for Adma Biologics (ADMA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings e
ADMA's Q3 Earnings Match Estimates, Revenues Beat on Strong Asceniv Sales
09:30am, Thursday, 06'th Nov 2025
ADMA Biologics posts strong Q3 revenues and record Asceniv demand, but shares slip as higher taxes temper net income growth.
ADMA Biologics, Inc. (ADMA) Q3 2025 Earnings Call Transcript
03:31am, Thursday, 06'th Nov 2025
ADMA Biologics, Inc. ( ADMA ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Adam Grossman - Co-Founder, President, CEO & Director Brad Tade - CFO & Treasurer Conference Call
Adma Biologics (ADMA) Q3 Earnings Match Estimates
07:25pm, Wednesday, 05'th Nov 2025
Adma Biologics (ADMA) came out with quarterly earnings of $0.16 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.15 per share a year ago.
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update
04:05pm, Wednesday, 05'th Nov 2025
3Q 2025 Total Revenue of $134.2 Million, a 12% YoY Increase 3Q 2025 GAAP Net Income of $36.4 Million, a 1% YoY Increase 3Q 2025 Adjusted EBITDA (1) of $58.7 Million, a 29% YoY Increase 3Q 2025 Adjus
Y Intercept Hong Kong Ltd Buys 38,809 Shares of ADMA Biologics Inc $ADMA
04:13am, Monday, 03'rd Nov 2025
Y Intercept Hong Kong Ltd boosted its stake in shares of ADMA Biologics Inc (NASDAQ: ADMA) by 107.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Com
This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here's Why
11:42am, Saturday, 01'st Nov 2025
California-based Palisades Investment Partners sold 398,647 shares of ADMA Biologics for an estimated $7.3 million in the third quarter. The transaction marked a full exit from ADMA, with Palisades re
ADMA Biologics Inc (ADMA) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Thursday, 30'th Oct 2025
Adma Biologics (ADMA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
D.A. Davidson & CO. Has $547,000 Holdings in ADMA Biologics Inc $ADMA
03:58am, Thursday, 30'th Oct 2025
D.A. Davidson and CO. boosted its holdings in ADMA Biologics Inc (NASDAQ: ADMA) by 21.4% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commissi
